Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patientsMark Sausen, Victor E. Velculescu, Derek Murphy et al.|Nature Communications|2015Cited by 484
Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic CancerThomas B. Karasic, Peter J. O’Dwyer, Mark H. O’Hara et al.|JAMA Oncology|2019Cited by 289
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinomaRebecca L. Porter, David T. Ting, Neelima K. C. Magnus et al.|Proceedings of the National Academy of Sciences|2019Cited by 129
Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score–matched analysisBrett L. Ecker, Robert E. Roses, Matthew T. McMillan et al.|Cancer|2015Cited by 115